Results 21 to 30 of about 38,894 (153)

Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: anin silicostructure-based approach [PDF]

open access: yes, 2020
In this study, the Nsp12-Nsp8 complex of SARS-CoV-2 was targeted with structure-based and computer-aided drug design approach because of its vital role in viral replication.
Turgut-Balık, Dilek   +9 more
core   +3 more sources

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2

open access: yesVirology Journal, 2022
AbstractA novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic of coronavirus disease 19. Coronaviruses, including SARS-CoV-2, use RNA-dependent RNA polymerase (RdRP) for viral replication and transcription.
Mitsuhiro Machitani   +7 more
openaire   +3 more sources

Digging for the Discovery of SARS-CoV-2 nsp12 Inhibitors: A Pharmacophore-Based and Molecular Dynamics Simulation Study [PDF]

open access: yesFuture Virology, 2021
Abstract Background: The severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a grave global threat causing Coronavirus Disease 2019 (COVID-19). The therapeutics are urgently needed to cure patients severely infected with COVID-19. The aim of the study was to investigate for potential candidates of nsp12 inhibitors by searching for ...
Fatemeh Sana Askari   +5 more
openaire   +2 more sources

RNA binding sites in NSP12 protein.

open access: yes, 2023
The structure of SARS-CoV-2 replication-transcription complex indicated in the PDB ID:501 6XEZ (Whole-model, A) and the SARS-CoV-2 NSP12 (Small-model, B). (C) RMSD comparison of Whole-model and Small-model. (PPTX)
Shiho Torii (12770667)   +16 more
core   +2 more sources

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

open access: yesGenome Biology, 2023
Abstract Background The mutational landscape of SARS-CoV-2 varies at the dominant viral genome sequence and minor genomic variant population. During the COVID-19 pandemic, an early substitution in the genome was the D614G change in the spike protein, associated with an increase in transmissibility. Genomes with D614G are
Goldswain, H.   +216 more
  +13 more sources

NSP12-RNA binding structure and comparison of thermodynamic stability.

open access: yes, 2023
(A) Overall view of NSP12 protein and location of the RDV. (B) RMSD comparison of RNA-binding proteins. (C) Comparison of the molecular vibrations of WT and each mutant.
Shiho Torii (12770667)   +16 more
core   +1 more source

Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2

open access: yesMolecules, 2022
The severe acute respiratory syndrome coronavirus 2, also known as SARS-CoV-2, is the causative agent of the COVID-19 global pandemic. SARS-CoV-2 has a highly conserved non-structural protein 12 (NSP-12) involved in RNA-dependent RNA polymerase (RdRp) activity.
Abdulelah Aljuaid   +10 more
openaire   +3 more sources

Conservation of NSP12 E802 and NSP6 I168 in coronaviruses.

open access: yes, 2021
Excel file with the frequency of NSP12 E802 (A) and frequency of NSP6 I168 (B). (XLSX)
Andres Merits (191446)   +19 more
core   +1 more source

Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the COVID-19 Virus

open access: yes, 2020
COVID-19 is the causative agent for the ongoing pandemic, and this virus belongs to the Coronaviridae family. Like other members of this family, the virus possesses a positive-sense single-stranded RNA genome.
deepak t nair, naveen narayanan
core   +1 more source

Home - About - Disclaimer - Privacy